The Paradox Nobody Expected
When people lose weight, they usually move more. Walking feels easier. Climbing stairs doesn't leave you breathless. But a landmark 2026 study from the Endocrine Society's annual meeting (ENDO 2026) reveals something surprising: people taking GLP-1 weight-loss medications actually move less, not more—even as the pounds come off.
What the Research Actually Found
Researchers analyzed Fitbit data from 753 adults using GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound. The findings were stark: average daily step counts dropped from 5,047 to 4,487 steps per day. Time spent in moderate-to-vigorous physical activity fell from 28 minutes to just 22 minutes daily.
The most telling part? The weight loss happened anyway. People lost pounds despite moving less.
Why This Matters More Than You Think
GLP-1 medications are powerful—but they have a hidden cost. While they're very effective at reducing body fat, they also strip away lean muscle mass. This is the mechanism behind the activity drop: your body simply has less muscle driving you forward.
Imagine renovating a house by removing both the worn-out furniture and some of the support beams. You've lightened the load, but you've also compromised the structure. Learn how Slimbr's doctors prevent this risk with your personal plan.

The Muscle Loss Problem: Real Numbers
Studies show that GLP-1 users can lose 25–40% of their weight loss as muscle mass—not just fat. If you drop 20 kg on medication, up to 8 kg could be lean tissue. That muscle loss explains why people feel less motivated to move: the biological engine running your daily activity has literally shrunk.
For women over 40—especially those in menopause—this is particularly concerning. Muscle mass is your metabolic engine and your protection against falls, fractures, and aging. Losing it undermines the very health benefits weight loss is supposed to deliver.
Take our free quiz to see if medical weight-loss support is right for you—your doctor can help you build a movement plan that protects your strength.
Three Science-Backed Ways to Protect Your Muscle While on GLP-1

Why Doctors Are Flagging This Now
The ENDO 2026 study is the first large investigation using continuous wearable data to track this pattern. What researchers found surprised even them: weight loss alone doesn't motivate movement. In fact, the opposite happened. This changes how clinicians should advise GLP-1 patients—because passive weight loss, without intentional muscle preservation, undermines long-term health.
The Real Goal: Healthy Weight Loss, Not Just Weight Loss
When you step on the scale, the number doesn't tell you whether you lost fat or muscle. You could lose 15 kg and be weaker, less mobile, and at higher risk for injury. Or you could lose 15 kg while building strength and feeling more capable than you have in years. The difference is structured exercise and adequate nutrition—not the medication itself.
Is Medical Weight Loss Right for You?
If you're interested in GLP-1 support, the right partner is a clinician who understands the muscle-loss risk and helps you build an exercise plan from day one. Slimbr's doctor-led approach includes this framework—medication combined with guidance on movement and nutrition, not medication alone. Start a free doctor consultation to discuss whether clinical weight-loss support fits your health goals.
The Bottom Line
The ENDO 2026 findings are a wake-up call, but not a reason to avoid GLP-1 treatment. They're a reason to combine medication with intention: strength work, adequate protein, and daily movement. Lose the weight and keep the muscle. That's the goal—and it's completely achievable with the right support.



